☰

Nathaniel Parsons - Publications

Affiliations: 
2018- Ophthalmology Medical University of South Carolina, Charleston, SC, United States 
Tree Info Grants Similar researchers PubMed Report error

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Parsons NB, Annamalai B, Rohrer B. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model. Translational Vision Science & Technology. 12: 17. PMID 37462980 DOI: 10.1167/tvst.12.7.17  0.71
2023 Rohrer B, Parsons N, Annamalai B, Nicholson C, Obert E, Jones B, Dick AD. Elastin Layer in Bruch's Membrane as a Target for Immunization or Tolerization to Modulate Pathology in the Mouse Model of Smoke-Induced Ocular Injury. Advances in Experimental Medicine and Biology. 1415: 67-71. PMID 37440016 DOI: 10.1007/978-3-031-27681-1_11  0.631
2021 Rohrer B, Parsons N, Annamalai B, Nicholson C, Obert E, Jones B, Dick AD. Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injury. Experimental Eye Research. 108755. PMID 34487725 DOI: 10.1016/j.exer.2021.108755  0.61
2021 Annamalai B, Parsons N, Nicholson C, Joseph K, Coughlin B, Yang X, Jones BW, Tomlinson S, Rohrer B. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration. Experimental Eye Research. 108583. PMID 33878326 DOI: 10.1016/j.exer.2021.108583  0.697
2021 Annamalai B, Parsons N, Nicholson C, Obert E, Jones B, Rohrer B. Subretinal Rather Than Intravitreal Adeno-Associated Virus-Mediated Delivery of a Complement Alternative Pathway Inhibitor Is Effective in a Mouse Model of RPE Damage. Investigative Ophthalmology & Visual Science. 62: 11. PMID 33830174 DOI: 10.1167/iovs.62.4.11  0.739
2020 Annamalai B, Parsons N, Brandon C, Rohrer B. The use of Matrigel combined with encapsulated cell technology to deliver a complement inhibitor in a mouse model of choroidal neovascularization. Molecular Vision. 26: 370-377. PMID 32476817  0.683
2020 Belhaj M, Annamalai B, Parsons N, Shuler A, Potts J, Rohrer B. Encapsulated Cell Technology for the Delivery of Biologics to the Mouse Eye. Journal of Visualized Experiments : Jove. PMID 32281978 DOI: 10.3791/60162  0.599
2020 Annamalai B, Nicholson C, Parsons N, Stephenson S, Atkinson C, Jones B, Rohrer B. Immunization Against Oxidized Elastin Exacerbates Structural and Functional Damage in Mouse Model of Smoke-Induced Ocular Injury. Investigative Ophthalmology & Visual Science. 61: 45. PMID 32207814 DOI: 10.1167/Iovs.61.3.45  0.671
2019 Parsons N, Annamalai B, Obert E, Schnabolk G, Tomlinson S, Rohrer B. Inhibition of the alternative complement pathway accelerates repair processes in the murine model of choroidal neovascularization. Molecular Immunology. 108: 8-12. PMID 30763805 DOI: 10.1016/J.Molimm.2019.02.001  0.634
2018 Annamalai B, Parsons N, Belhaj M, Brandon C, Potts J, Rohrer B. Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model. Translational Vision Science & Technology. 7: 3. PMID 29576927 DOI: 10.1167/Tvst.7.2.3  0.73
2018 Schnabolk G, Parsons N, Obert E, Annamalai B, Nasarre C, Tomlinson S, Lewin AS, Rohrer B. Delivery of CR2-fH Using AAV Vector Therapy as Treatment Strategy in the Mouse Model of Choroidal Neovascularization. Molecular Therapy. Methods & Clinical Development. 9: 1-11. PMID 29234687 DOI: 10.1016/J.Omtm.2017.11.003  0.645
Show low-probability matches.